Jim Simons Renaissance Technologies
AUM
$75.2B
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Quarter Return
+22.71%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$92.1B
AUM Growth
+$92.1B
(-8%)
Cap. Flow
-$22.3B
Cap. Flow
% of AUM
-24.18%
Top 10 Holdings %
Top 10 Hldgs %
13.27%
Holding
3,901
New
568
Increased
1,136
Reduced
1,633
Closed
559
Top Buys
| 1 |
NVIDIA
NVDA
|
$524M |
| 2 |
Peloton Interactive
PTON
|
$465M |
| 3 |
Amazon
AMZN
|
$312M |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
$290M |
| 5 |
NetEase
NTES
|
$264M |
Top Sells
| 1 |
Zoom
ZM
|
$965M |
| 2 |
Pinduoduo
PDD
|
$805M |
| 3 |
AbbVie
ABBV
|
$794M |
| 4 |
Chipotle Mexican Grill
CMG
|
$757M |
| 5 |
Bristol-Myers Squibb
BMY
|
$750M |
Sector Composition
| 1 | Healthcare | 20.82% |
| 2 | Technology | 16.68% |
| 3 | Consumer Discretionary | 11.2% |
| 4 | Communication Services | 10.87% |
| 5 | Consumer Staples | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Novo Nordisk
NVO
$250B
| $1.87B | 2.04% | 26,841,171 -1,280,060 | -5% | -$89.4M |
|
2
Baidu
BIDU
$32.8B
| $1.86B | 2.02% | 8,589,864 -1,955,294 | -19% | -$423M |
|
|
3
Pinduoduo
PDD
$172B
| $1.27B | 1.38% | 7,146,243 -4,529,530 | -39% | -$805M |
|
4
VeriSign
VRSN
$25.4B
| $1.24B | 1.34% | 5,721,534 -851,656 | -13% | -$184M |
|
|
5
Bristol-Myers Squibb
BMY
$95.7B
| $1.15B | 1.24% | 18,480,630 -12,095,797 | -40% | -$750M |
|
6
Palo Alto Networks
PANW
$127B
| $1.08B | 1.18% | 3,052,729 -875,875 | -22% | -$311M |
|
7
Atlassian
TEAM
$46.9B
| $1.02B | 1.1% | 4,345,020 -1,552,794 | -26% | -$363M |
|
8
Monster Beverage
MNST
$60.9B
| $946M | 1.03% | 10,229,660 -2,254,630 | -18% | -$209M |
|
9
Target
TGT
$43.6B
| $944M | 1.02% | 5,345,665 -1,483,532 | -22% | -$262M |
|
10
Vertex Pharmaceuticals
VRTX
$101B
| $845M | 0.92% | 3,575,930 -1,631,002 | -31% | -$385M |
|
|
11
Chipotle Mexican Grill
CMG
$56.3B
| $823M | 0.89% | 593,242 -545,800 | -48% | -$757M |
|
|
12
Zoom
ZM
$24.4B
| $806M | 0.87% | 2,388,534 -2,859,325 | -54% | -$965M |
|
13
Kroger
KR
$44.5B
| $783M | 0.85% | 24,647,215 -4,480,873 | -15% | -$142M |
|
14
Biogen
BIIB
$19.4B
| $744M | 0.81% | 3,037,762 -779,199 | -20% | -$191M |
|
15
Franco-Nevada
FNV
$35.9B
| $695M | 0.75% | 5,542,590 +188,407 | +4% | +$23.6M |
|
16
Etsy
ETSY
$5.31B
| $681M | 0.74% | 3,830,108 +142,247 | +4% | +$25.3M |
|
17
Molina Healthcare
MOH
$9.7B
| $659M | 0.72% | 3,100,365 -254,794 | -8% | -$54.2M |
|
|
18
AbbVie
ABBV
$370B
| $650M | 0.71% | 6,062,575 -7,408,228 | -55% | -$794M |
|
|
ABMD
19
DELISTED
Abiomed Inc
ABMD
| $646M | 0.7% | 1,993,800 -263,323 | -12% | -$85.4M |
|
|
ALXN
20
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $643M | 0.7% | 4,113,704 -643,539 | -14% | -$101M |
|
21
Vodafone
VOD
$28.8B
| $609M | 0.66% | 36,982,976 -2,509,224 | -6% | -$41.4M |
|
22
United Therapeutics
UTHR
$13.8B
| $548M | 0.59% | 3,607,291 -101,727 | -3% | -$15.4M |
|
23
F5
FFIV
$17.9B
| $531M | 0.58% | 3,018,836 -154,138 | -5% | -$27.1M |
|
24
Fortinet
FTNT
$60.5B
| $526M | 0.57% | 3,540,484 -1,102,203 | -24% | -$164M |
|
25
GSK
GSK
$79.5B
| $525M | 0.57% | 14,271,421 -4,058,233 | -22% | -$149M |
|